Hosted on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro deal
SCS will contribute the most significant share to that total, around $4.6bn by 2034. Boston Scientific has 55% of the current market share, followed by Medtronic and then Abbott, as per analysis ...
Boston Scientific (NYSE:BSX) Downgraded by StockNews.com to “Hold”
Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...
Boston Scientific (NYSE:BSX) Upgraded at StockNews.com
StockNews.com upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. A number of other equities analysts ...